![](/img/cover-not-exists.png)
Time to secondary progression in patients with multiple sclerosis who were treatedwith first generation immunomodulating drugs
Tedeholm, H., Lycke, J., Skoog, B., Lisovskaja, V., Hillert, J., Dahle, C., Fagius, J., Fredrikson, S., Landtblom, A.-M., Malmestrom, C., Martin, C., Piehl, F., Runmarker, B., Stawiarz, L., Vrethem, MVolume:
19
Language:
english
Journal:
Multiple Sclerosis Journal
DOI:
10.1177/1352458512463764
Date:
May, 2013
File:
PDF, 893 KB
english, 2013